So much as science is an art, it is really an art of seeing and hearing nature in its most minute form in any setting, big or small. Sometimes nature gives us clues in the many meticulous observations noted by scientists. Other times, the absence of any expected phenomenon can be just as enlightening to the researcher.
Next generations sequencing (NGS) has expanded beyond research applications to deliver clinically actionable information that can effectively guide therapeutic decision-making. Cancer researchers today seek to translate the immense volume of genomic data to clinical applications .
In 2012, 8.2 million people died of cancer â€“ an estimated 14.6% of all deaths worldwide. The number of cancer diagnoses globally is projected to increase 57% (approximately 8 million new cases) between now and 2030, influenced in part by an aging population. That same year, in 2012, the World Health Organization announced cancer had officially replaced heart disease as the primary cause of death in many developed and developing countries worldwide (http://www.who.int/mediacentre/factsheets/fs297/en/). This fact is fueling increased demand for research and public health campaigns to fight cancer both here at home and abroad. This article probes the discoveries leading up to the invention of whole-genome sequencing used widely today.